These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2694422)

  • 1. Indirect activation of blood coagulation in colon cancer.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    Thromb Haemost; 1989 Dec; 62(4):1062-6. PubMed ID: 2694422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen-fibrin transformation in situ in renal cell carcinoma.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    Anticancer Res; 1990; 10(3):579-82. PubMed ID: 2114816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of blood coagulation factors in situ in pancreatic carcinoma.
    Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W
    Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen deposition without thrombin generation in primary human breast cancer tissue.
    Costantini V; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM
    Cancer Res; 1991 Jan; 51(1):349-53. PubMed ID: 1670992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrin formation on vessel walls in hyperplastic and malignant prostate tissue.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Moritz TE; Rousseau SM; Stump DC
    Cancer; 1991 Mar; 67(5):1377-83. PubMed ID: 1703919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding.
    Zacharski LR; Memoli VA; Morain WD; Schlaeppi JM; Rousseau SM
    Thromb Haemost; 1995 May; 73(5):793-7. PubMed ID: 7482405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression evaluation of in loco coagulation system in colorectal cancer].
    Sierko E; Tokajuk P; Butkiewicz A; Sulkowski S; Zimnoch L; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2005 Feb; 18(104):176-9. PubMed ID: 17877125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining.
    Kohga S; Harvey SR; Weaver RM; Markus G
    Cancer Res; 1985 Apr; 45(4):1787-96. PubMed ID: 3884145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    Am J Clin Pathol; 1990 Apr; 93(4):516-21. PubMed ID: 1690950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of tissue factor and tissue factor pathway inhibitor in situ in laryngeal carcinoma.
    Wojtukiewicz MZ; Zacharski LR; Ruciñska M; Zimnoch L; Jaromin J; Rózañska-Kudelska M; Kisiel W; Kudryk BJ
    Thromb Haemost; 1999 Dec; 82(6):1659-62. PubMed ID: 10613652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of blood coagulation inhibitors in colon cancer].
    Sierko E; Zawadzki RJ; Zimnoch L; Sulkowski S; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2006 Apr; 20(118):462-7. PubMed ID: 16886577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell procoagulant and urokinase expression in carcinoma of the ovary.
    Zacharski LR; Memoli VA; Ornstein DL; Rousseau SM; Kisiel W; Kudryk BJ
    J Natl Cancer Inst; 1993 Aug; 85(15):1225-30. PubMed ID: 8331683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.
    Wojtukiewicz MZ; Sierko E; Zacharski LR; Zimnoch L; Kudryk B; Kisiel W
    Semin Thromb Hemost; 2003 Jun; 29(3):291-300. PubMed ID: 12888933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of components of fibrinolytic pathways in situ in laryngeal cancer.
    Wojtukiewicz MZ; Sierko E; Zacharski LR; Rózanska-Kudelska M; Zimnoch L
    Semin Thromb Hemost; 2003 Jun; 29(3):317-20. PubMed ID: 12888936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathways of coagulation/fibrinolysis activation in malignancy.
    Zacharski LR; Wojtukiewicz MZ; Costantini V; Ornstein DL; Memoli VA
    Semin Thromb Hemost; 1992 Jan; 18(1):104-16. PubMed ID: 1574711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.